CLDP, in cooperation with the U.S. Patent and Trademark Office (USPTO) and the U.S. Embassy in Ukraine, held a three-day workshop in May 2011 on Identification and Interdiction of Counterfeit Medicines in Kyiv, Ukraine. The workshop worked to increase the understanding of Ukraine's officials, specifically its law enforcement and regulatory agencies, of the most effective methods and techniques to combat the trade in counterfeit medicines. Ukrainian participants included investigators, prosecutors, judges, customs officials, government regulators, NGOs, and private sector representatives.

One of the main outcomes from the program was a recommendation to the Rada, Ukraine’s Parliament, to adopt Draft Law 7146 which introduced criminal penalties for production of and trade in counterfeit medicines for the first time. Last week, the Rada adopted the law establishing deterrent level penalties for the production and distribution of counterfeit medicines. These recent developments are a step forward in ensuring adequate criminal penalties for the production of and trade in counterfeit medicines and highlighting the importance of effective enforcement in Ukraine.